Brevan Howard Capital Management LP Amicus Therapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 18,266 shares of FOLD stock, worth $165,855. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,266
Previous 44,360
58.82%
Holding current value
$165,855
Previous $473,000
63.64%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
311MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$266 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA28.5MShares$258 Million0.05% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$221 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$220 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$210 Million3.18% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.55B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...